D
Dick Menzies
Researcher at McGill University
Publications - 317
Citations - 17169
Dick Menzies is an academic researcher from McGill University. The author has contributed to research in topics: Tuberculosis & Latent tuberculosis. The author has an hindex of 62, co-authored 282 publications receiving 14518 citations. Previous affiliations of Dick Menzies include McGill University Health Centre & University of Sydney.
Papers
More filters
Journal ArticleDOI
Incidence of Serious Side Effects from First-Line Antituberculosis Drugs among Patients Treated for Active Tuberculosis
Daphne Yee,Chantal Valiquette,Marthe Pelletier,Isabelle Parisien,Isabelle Rocher,Dick Menzies +5 more
TL;DR: The incidence of pyrazinamide-induced hepatotoxicity and rash during treatment for active TB was substantially higher than with the other first-line anti-TB drugs, and higher than previously recognized.
Journal ArticleDOI
Diagnostic accuracy of serological tests for covid-19: systematic review and meta-analysis.
Mayara Lisboa Bastos,Mayara Lisboa Bastos,Gamuchirai Tavaziva,S.K. Abidi,Jonathon R. Campbell,Jonathon R. Campbell,Louis-Patrick Haraoui,James C. Johnston,Zhiyi Lan,Stephanie Law,Emily MacLean,Anete Trajman,Anete Trajman,Dick Menzies,Dick Menzies,Andrea Benedetti,Andrea Benedetti,Faiz Ahmad Khan,Faiz Ahmad Khan +18 more
TL;DR: Higher quality clinical studies assessing the diagnostic accuracy of serological tests for covid-19 are urgently needed, as available evidence does not support the continued use of existing point-of-care serological Tests for coronavirus disease-2019.
Journal ArticleDOI
Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case–control studies
TL;DR: Patients in hospital who received proton pump inhibitors were at increased risk of C. difficile diarrhea, and this was associated with female sex and prior renal failure.
Journal ArticleDOI
Multidrug Resistant Pulmonary Tuberculosis Treatment Regimens and Patient Outcomes: An Individual Patient Data Meta-analysis of 9,153 Patients
Shama D. Ahuja,David Ashkin,Monika Avendano,Rita Banerjee,Melissa Bauer,Jamie N. Bayona,Mercedes C. Becerra,Mercedes C. Becerra,Andrea Benedetti,Marcos Burgos,Rosella Centis,Eward D. Chan,Chen Yuan Chiang,Helen Cox,Lia D'Ambrosio,Kathy DeRiemer,Nguyen Huy Dung,Donald A. Enarson,Dennis Falzon,Katherine Flanagan,Jennifer Flood,Maria de Lourdes García-García,Neel R. Gandhi,Reuben Granich,Maria G. Hollm-Delgado,Timothy H. Holtz,Michael D. Iseman,Leah G. Jarlsberg,Salmaan Keshavjee,Hye-Ryoun Kim,Won-Jung Koh,Joey Lancaster,Christophe Lange,Wiel C M de Lange,Vaira Leimane,Chi Chiu Leung,Jiehui Li,Dick Menzies,Giovanni Battista Migliori,Sergey P. Mishustin,Carole D. Mitnick,Masa Narita,Philly O'Riordan,Madhukar Pai,Domingo Palmero,Seung-kyu Park,Geoffrey Pasvol,José María Peña,Carlos Pérez-Guzmán,M. I. D. Quelapio,Alfredo Ponce-de-León,Vija Riekstina,Jérôme Robert,Sarah Royce,H. Simon Schaaf,Kwonjune J. Seung,Lena Shah,Tae Sun Shim,Sonya Shin,Yuji Shiraishi,José Sifuentes-Osornio,Giovanni Sotgiu,Matthew Strand,Payam Tabarsi,Thelma E. Tupasi,Robert van Altena,Martie van der Walt,Tjip S. van der Werf,Mario H. Vargas,Pirett Viiklepp,Janice Westenhouse,Wing Wai Yew,Jae-Joon Yim +72 more
TL;DR: Findings from a collaborative, individual patient-level meta-analysis of treatment outcomes among patients with multidrug-resistant tuberculosis are reported.
Journal ArticleDOI
The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis
Keertan Dheda,Tawanda Gumbo,Gary Maartens,Kelly E. Dooley,Ruth McNerney,Megan Murray,Jennifer Furin,Edward A. Nardell,Leslie London,Erica Lessem,Grant Theron,Paul D. van Helden,Stefan Niemann,Matthias Merker,David W. Dowdy,Annelies Van Rie,Annelies Van Rie,Gilman Kit Hang Siu,Jotam G. Pasipanodya,Camilla Rodrigues,Taane G. Clark,F. A. Sirgel,Aliasgar Esmail,Hsien-Ho Lin,Sachin R Atre,H. Simon Schaaf,Kwok Chiu Chang,Christoph Lange,Payam Nahid,Zarir F Udwadia,C. Robert Horsburgh,Gavin J. Churchyard,Gavin J. Churchyard,Dick Menzies,Anneke C. Hesseling,Eric L. Nuermberger,Helen McIlleron,Kevin P. Fennelly,Eric Goemaere,Ernesto Jaramillo,Marcus Low,Carolina Morán Jara,Nesri Padayatchi,Robin M. Warren +43 more
TL;DR: Several lines of evidence suggest that alternative mechanisms-including pharmacokinetic variability, induction of efflux pumps that transport the drug out of cells, and suboptimal drug penetration into tuberculosis lesions-are likely crucial to the pathogenesis of drug-resistant tuberculosis.